Published by Josh White on 31st December 2024
(Sharecast News) - ValiRx, a life science company specialising in early-stage cancer therapeutics and women's health, announced a further amendment to its letter of intent with TheoremRx regarding the proposed sub-license of VAL201 on Tuesday.
URL: http://www.digitallook.com/dl/news/story/34784027/...